Oct 8, 2026 12:37PM
Oct 8, 2026 07:45AM
Oct 8, 2026 07:45AM
Aug 6, 2026 06:59AM
May 7, 2026 06:59AM
Mar 19, 2026 08:31AM
Mar 19, 2026 08:30AM Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030
Feb 26, 2026 06:59AM
Feb 3, 2026 08:30AM
Feb 3, 2026 08:30AM
Dec 8, 2025 02:55AM
Dec 6, 2025 09:00AM
Nov 6, 2025 06:59AM
Oct 15, 2025 04:30PM Viatris acquires Aculys Pharma for Japan CNS drug rights
Oct 15, 2025 04:30PM
Aug 7, 2025 06:59AM
May 8, 2025 06:59AM
Apr 7, 2025 07:15AM
Feb 27, 2025 07:05PM
Feb 27, 2025 06:45AM
Nov 7, 2024 06:59AM Viatris Reports Third Quarter Financial Results for 2024
Oct 16, 2024 04:34PM
Sep 18, 2024 11:34AM
Sep 18, 2024 11:30AM
Sep 17, 2024 08:45PM
Sep 10, 2024 07:00PM
Sep 10, 2024 11:40AM
Sep 4, 2024 03:30AM Viatris Announces Cash Tender Offers for Certain Outstanding Notes
Aug 8, 2024 06:59AM
Jul 3, 2024 08:31AM
Jul 3, 2024 08:30AM
Jun 3, 2024 06:59AM
Jun 3, 2024 06:59AM
May 21, 2024 06:30PM
May 21, 2024 06:59AM Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale
May 9, 2024 06:59AM
Feb 28, 2024 08:08AM
Feb 28, 2024 06:30AM
Nov 7, 2023 04:02PM
Oct 2, 2023 02:26AM
Oct 1, 2023 05:00PM
Aug 7, 2023 06:59AM Viatris Reports Strong Financial and Operational Results for Second Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges[1]
May 8, 2023 06:59AM
Feb 27, 2023 06:00AM
Jan 3, 2023 09:00AM
Dec 6, 2022 06:00AM
Nov 29, 2022 08:42AM
Nov 29, 2022 08:00AM
Nov 10, 2022 04:05PM Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights
Nov 10, 2022 04:05PM

1,199,265 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All